Press Releases

ALBANY, NY - Sep 1, 2015 - According to a recently released market research report by Transparency Market Research, the global market for biopsy devices,which was valued at US$1.3 billion in 2011, is estimated to reporta CAGR of 6.6%during the forecast period of 2012-2018, thereby reaching a market value of US$2.1 billion by the year 2018. The report is titled ‘Biopsy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018’. 

According to this market research report, the global biopsy devices market is propelled by therising incidence of cancer all across the globe, and greater awareness regarding frequent medical screenings, and greater preference for minimally invasive surgical methods in the field of medicine. Biopsy is the very first step in the diagnosis and treatment of cancer. Biopsy devices are also of great significance in the post-diagnosis stage of cancer, which mostly involves screenings on a regular basis. The rising demand for disposable needles and devices can be attributed to the fact that patients these days are well aware of and concerned about infectious diseases that spread via invasive treatment and diagnostic devices and tools. 

This TMR report has segmented the global biopsy devices market on the basis of products and geography. Based on the type of product, the global biopsy devices market is categorized into biopsy forceps, needle-based biopsy guns, biopsy guidance systems, biopsy needles, and others. The fastest growing segment in the global biopsy devices market is that of needle-based biopsy guns. Core needle biopsy devices, vacuum-assisted biopsy devices, and fine needle aspiration biopsy devices are the subcategories of the needle-based biopsy guns segment. The needle-based biopsy guns market segment is mainly driven by greater preference for disposable devices over reusable devices. It is also anticipated that the market for needle-based biopsy guns will grow at an 8% CAGR in the forthcoming years. Under the needle-based biopsy guns segment, the segment ofvacuum-assisted biopsy devices witnesses the highest demand,since these devices, apart from being minimally invasive, are very efficient. 

As per this research report, geographically, the global market for biopsy devices is segmented into Europe, Asia Pacific, North America, and Rest of the World. The leading regional market that dominates the global biopsy devices market is North America. However, as per industry forecasts, the Asia Pacific biopsy devices market will witness the highest rate of growth in the years to come. The growth of the Asia Pacific biopsy devices market can be attributed to favorable economic and demographic conditions. The biopsy devices markets in developed regions like Europe and North America are essentially driven by research and innovation. Also, economic development and technological advancements are the two main factors driving the biopsy devices market in Asia.

Browse the full Global  Biopsy Devices Market (Disposable & Reusable Needles, Hot & Cold Forceps, Needle-based Biopsy Guns, VAB, CNB, FNAB Devices, Guidance Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018 report at http://www.transparencymarketresearch.com/biopsy-devices-market.html

UK Biopsy, Hologic, Inc., Devicor Medical Products, Inc., Carefusion Corporation, and Cardinal Health Inc. are a few key participantsoperating in the worldwide market for biopsy devices market.